{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T22:04:59Z","timestamp":1766181899406,"version":"3.37.3"},"reference-count":26,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"crossref","award":["PR-R17-0916-22001"],"award-info":[{"award-number":["PR-R17-0916-22001"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIHR Oxford Clinical Research Facility"},{"name":"Biomedical Research Centre"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["CV220-036","CV220-036\/1","PR-R17-0916-22001"],"award-info":[{"award-number":["CV220-036","CV220-036\/1","PR-R17-0916-22001"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To understand community seroprevalence of SARS-CoV-2 in children and adolescents. This is vital to understanding the susceptibility of this cohort to COVID-19 and to inform public health policy for disease control such as immunisation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>We conducted a community-based cross-sectional seroprevalence study in participants aged 0\u201318\u2009years old recruiting from seven regions in England between October 2019 and June 2021 and collecting extensive demographic and symptom data. Serum samples were tested for antibodies against SARS-CoV-2 spike and nucleocapsid proteins using Roche assays processed at UK Health Security Agency laboratories. Prevalence estimates were calculated for six time periods and were standardised by age group, ethnicity and National Health Service region.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Post-first wave (June\u2013August 2020), the (anti-spike IgG) adjusted seroprevalence was 5.2%, varying from 0.9% (participants 10\u201314\u2009years old) to 9.5% (participants 5\u20139\u2009years old). By April\u2013June 2021, this had increased to 19.9%, varying from 13.9% (participants 0\u20134\u2009years old) to 32.7% (participants 15\u201318\u2009years old). Minority ethnic groups had higher risk of SARS-CoV-2 seropositivity than white participants (OR 1.4, 95%\u2009CI 1.0 to 2.0), after adjusting for sex, age, region, time period, deprivation and urban\/rural geography. In children &lt;10\u2009years, there were no symptoms or symptom clusters that reliably predicted seropositivity. Overall, 48% of seropositive participants with complete questionnaire data recalled no symptoms between February 2020 and their study visit.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Approximately one-third of participants aged 15\u201318\u2009years old had evidence of antibodies against SARS-CoV-2 prior to the introduction of widespread vaccination. These data demonstrate that ethnic background is independently associated with risk of SARS-CoV-2 infection in children.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04061382\">NCT04061382<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2022-324375","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T17:25:14Z","timestamp":1658337914000},"page":"123-130","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019\u20132021"],"prefix":"10.1136","volume":"108","clinical-trial-number":[{"clinical-trial-number":"nct04061382","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4048-1035","authenticated-orcid":false,"given":"Helen","family":"Ratcliffe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K S","family":"Tiley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayatri","family":"Amirthalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Vichos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Morey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N L","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Marinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Plested","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parvinder","family":"Aley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva P","family":"Galiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3410-7642","authenticated-orcid":false,"given":"Saul N","family":"Faust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8961-8055","authenticated-orcid":false,"given":"Clare S","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Roderick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Shackley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8701-4912","authenticated-orcid":false,"given":"Sam J","family":"Oddie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Lees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D P J","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Raman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6979-9207","authenticated-orcid":false,"given":"Stephen","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9862-5161","authenticated-orcid":false,"given":"Paul","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Cockerill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Lopez Bernal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Linley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Elizabeth","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Voysey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D","family":"Snape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"doi-asserted-by":"crossref","unstructured":"Ward H , Atchison CJ , Whitaker M . Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults. medRxiv 2020:2020.08.12.20173690.","key":"2023051801501146000_108.2.123.1","DOI":"10.1101\/2020.08.12.20173690"},{"doi-asserted-by":"publisher","key":"2023051801501146000_108.2.123.2","DOI":"10.1126\/science.abl9551"},{"doi-asserted-by":"publisher","key":"2023051801501146000_108.2.123.3","DOI":"10.1136\/archdischild-2020-320558"},{"doi-asserted-by":"publisher","key":"2023051801501146000_108.2.123.4","DOI":"10.1016\/S1473-3099(20)30882-3"},{"key":"2023051801501146000_108.2.123.5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jinf.2021.02.022","article-title":"SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: prospective, National observational cohort surveillance, July-December 2020, England","volume":"82","author":"Mensah","year":"2021","journal-title":"J Infect"},{"unstructured":"Ministry of housing calg . The English Indices of Deprivation 2019 (IoD2019) - Statistical release. Ministry of housing, communities and local government, 2019.","key":"2023051801501146000_108.2.123.6"},{"unstructured":"NHS . Digital NHS, 2021. Available: https:\/\/digital.nhs.uk [Accessed 17 Jan 2022].","key":"2023051801501146000_108.2.123.7"},{"unstructured":"association Lg . Child health information services, 2021. Available: https:\/\/www.local.gov.uk\/topics\/social-care-health-and-integration\/public-health\/children-public-health-transfer\/child-health-information-services [Accessed 17 Jan 2022].","key":"2023051801501146000_108.2.123.8"},{"doi-asserted-by":"publisher","key":"2023051801501146000_108.2.123.9","DOI":"10.1016\/j.jinf.2020.08.037"},{"doi-asserted-by":"crossref","unstructured":"Hartley JEK , Levin K , Currie C . A new version of the HBSC Family Affluence Scale - FAS III : Scottish qualitative findings from the international FAS Development Study Child Indicators Research, 2016: 233\u201345.","key":"2023051801501146000_108.2.123.10","DOI":"10.1007\/s12187-015-9325-3"},{"unstructured":"Statistics OoN . Household questionnaire England, 2011. Available: https:\/\/www.ons.gov.uk\/file?uri=\/census\/censustransformationprogramme\/consultations\/the2021censusinitialviewoncontentforenglandandwales\/2011censusquestionnaireenglandh1.pdf [Accessed 17 Jan 2022].","key":"2023051801501146000_108.2.123.11"},{"doi-asserted-by":"publisher","key":"2023051801501146000_108.2.123.12","DOI":"10.3390\/ijerph14121540"},{"unstructured":"Duggan J , Andrews N , Brooks T . Evaluation of Roche Elecsys anti- SARS-CoV-2 serology assay for the detection of anti-SARS-CoV-2 antibodies. England PH, assets publishing service, 2020.","key":"2023051801501146000_108.2.123.13"},{"unstructured":"Duggan J , Otter A , Andrews N . Evaluation of Roche Elecsys anti- SARS-CoV-2 S serology assay for the detection of anti-SARS-CoV-2 S antibodies. assets publishing service, 2021.","key":"2023051801501146000_108.2.123.14"},{"unstructured":"analysis IfG . Timeline of UK government coronavirus lockdowns, 2021. Available: https:\/\/www.instituteforgovernment.org.uk\/charts\/uk-government-coronavirus-lockdowns [Accessed 19 Jan 2022].","key":"2023051801501146000_108.2.123.15"},{"unstructured":"England PH . National COVID-19 surveillance reports, 2022. Available: https:\/\/www.gov.uk\/government\/publications\/national-covid-19-surveillance-reports [Accessed 19 Jan 2022].","key":"2023051801501146000_108.2.123.16"},{"unstructured":"Wohland PBM , Rees P , Norman P , et al . NewETHPOP- evaluation, revision and extension of ethnic population projections.","key":"2023051801501146000_108.2.123.17"},{"unstructured":"StataCorp . Stata statistical software: release 17. College Station: TX: StataCorp LLC, 2021.","key":"2023051801501146000_108.2.123.18"},{"unstructured":"(DHSC) OatDfHaSC . Coronavirus (COVID-19) infection survey, antibody and vaccination data, 2021. Available: ons.gov.uk","key":"2023051801501146000_108.2.123.19"},{"unstructured":"J A . COVID-19 schools infection survey, England: round 6, pupil antibody data, 2021. Available: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/bulletins\/covid19schoolsinfectionsurveyengland\/round6pupilantibodydatajune2021 [Accessed 27 Jan 2022].","key":"2023051801501146000_108.2.123.20"},{"key":"2023051801501146000_108.2.123.21","doi-asserted-by":"crossref","first-page":"e0078621","DOI":"10.1128\/spectrum.00786-21","article-title":"Sars antibody testing in children: development of oral fluid assays for IgG measurements","volume":"10","author":"Hoschler","year":"2022","journal-title":"Microbiol Spectr"},{"unstructured":"Statistics OfN . Coronavirus (COVID-19), 2022. Available: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases [Accessed 26 Jan 2022].","key":"2023051801501146000_108.2.123.22"},{"key":"2023051801501146000_108.2.123.23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S2352-4642(21)00061-4","article-title":"SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study","volume":"5","author":"Ladhani","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"unstructured":"Workforce Team ND . NHS Workforce Statistics - November 2021 (Including selected provisional statistics for December 2021. Digital N, 2022.","key":"2023051801501146000_108.2.123.24"},{"key":"2023051801501146000_108.2.123.25","doi-asserted-by":"crossref","first-page":"30884","DOI":"10.1016\/S1473-3099(20)30884-7","article-title":"Kinetics and seroprevalence of SARS-CoV-2 antibodies in children","volume":"21","author":"Roarty","year":"2021","journal-title":"Lancet Infect Dis"},{"doi-asserted-by":"crossref","unstructured":"Harris RJ , Whitaker HJ , Andrews NJ . Serological surveillance of SARS-CoV-2: six-month trends and antibody response in a cohort of public health workers. medRxiv 2021:2020.10.21.20216689.","key":"2023051801501146000_108.2.123.26","DOI":"10.1101\/2020.10.21.20216689"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2022-324375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:54:22Z","timestamp":1684400062000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2022-324375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1,19]]},"published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1136\/archdischild-2022-324375"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2022-324375","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"type":"print","value":"0003-9888"},{"type":"electronic","value":"1468-2044"}],"subject":[],"published":{"date-parts":[[2022,7,20]]}}}